IMARC Group’s report titled “Enteric Softgel Capsules Market Report by Type (Gelatin Capsules, Non-Gelatin Softgel Capsules), Application (Health Supplements, Pharmaceuticals), Distribution Channel (Supermarkets and Hypermarkets, Pharmacy and Drug Stores, Online Stores), and Region 2024-2032” , The global enteric softgel capsules market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.
Factors Affecting the Growth of the Enteric Softgel Capsules Industry:
- Focus on Targeted Drug Delivery:
The pharmaceutical industry is focusing more on targeted drug delivery systems in 2024 to make treatments more effective and reduce side effects. Enteric softgel capsules are designed to release medicine in specific parts of the digestive system, like the lower intestine, without being affected by stomach acid. This is especially helpful for drugs that need precise delivery to work well.
- Higher Demand for Health Supplements:
More people are choosing nutraceuticals and dietary supplements to stay healthy and prevent illnesses. In 2024, enteric softgel capsules are becoming popular for these products because they protect sensitive ingredients from stomach acid and improve absorption in the intestines. This growing interest in wellness has significantly increased the use of enteric softgel capsules.
- Personalized Medicine on the Rise:
Personalized medicine is all about creating treatments that suit individual needs, and it’s gaining popularity in 2024. Enteric softgel capsules are perfect for this because they can be customized to provide specific doses and release medicines in a controlled way. This trend is encouraging new developments in advanced capsule formulations to better meet patient needs.
Grab a sample PDF of this report: https://www.imarcgroup.com/enteric-softgel-capsules-market/requestsample
Leading Companies Operating in the Global Enteric Softgel Capsules Industry:
- Aenova Group GmbH
- BASF SE
- Catalent, Inc.
- Colorcon Inc.
- Fuji Capsule Co. Ltd.
- Lonza Group AG
- Now Health Group, Inc.
- ProCaps Group
- Super Spectrim
- Thermo Fisher Scientific, Inc.
Enteric Softgel Capsules Market Report Segmentation:
Breakup by Type:
- Gelatin Capsules
- Non-Gelatin Softgel Capsules
Breakup by Application:
- Health Supplements
- Pharmaceuticals
Breakup by Distribution Channel:
- Supermarkets and Hypermarkets
- Pharmacy and Drug Stores
- Online Stores
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Enteric Softgel Capsules Market Trends:
The market for enteric softgel capsules is growing quickly due to trends like targeted drug delivery, the rising demand for health supplements, and personalized medicine. These capsules are becoming essential for delivering medicines and supplements in an effective and innovative way. As industries continue to advance, enteric softgel capsules are expected to play a key role in meeting consumer and patient demands.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145
